Kuo Minnie 4

What Happened
Minnie Kuo, Chief Operating Officer of Pliant Therapeutics, reported a sale of 6,917 shares (code S) on January 20, 2026. The weighted average sale price reported is $1.28 per share, for a total value of approximately $8,854. This sale was executed under a nondiscretionary Rule 10b5-1 arrangement to satisfy tax withholding obligations related to the vesting of previously granted restricted stock units (RSUs), so it is a routine tax-withholding sale rather than an open-market discretionary trade.

Key Details

• Transaction date listed: January 20, 2026 (weighted average sale prices reflect trades from Jan 20–22, 2026).
• Price: weighted average $1.28 per share (individual trade prices ranged $1.245–$1.33).
• Shares sold: 6,917; Proceeds ≈ $8,854.
• Amount owned following the transaction: not provided in the supplied filing details.
• Footnote: Sale was nondiscretionary under a 10b5-1 plan and executed by a broker on behalf of a group of employees to cover withholding; the filer will provide breakdown of shares sold at each price on request.
• Timeliness: Filed Jan 22, 2026 for a Jan 20, 2026 transaction — appears timely (not marked late).

Context
Sales to cover tax withholding on vested RSUs are common and typically reflect administrative needs rather than a personal view on the company’s prospects. The 10b5-1 plan and broker-managed execution indicate the sale was pre-arranged and nondiscretionary.